Quick Answer
Quoin Pharmaceuticals, Ltd. reported Total Assets of $20.39 million for fiscal year 2025.
Quoin Pharmaceuticals, Ltd. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $20.39M | +29.8% |
| 2024 | $15.71M | +29.1% |
| 2023 | $12.17M | -15.8% |
| 2022 | $14.46M | +54.5% |
| 2021 | $9.36M | +579.1% |
| 2020 | $1.38M | -93.5% |
| 2019 | $21.32M | +3.3% |
| 2018 | $20.64M | -32.1% |
| 2017 | $30.37M | -10.4% |
| 2016 | $33.91M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $6.42M | -43.6% | -27.9% |
| June 30, 2025 | $8.91M | -36.6% | -31.2% |
| March 31, 2025 | $12.96M | -19.6% | -17.5% |
| December 31, 2024 | $15.71M | +29.1% | +37.9% |
| September 30, 2024 | $11.39M | -24.4% | -19.0% |
| June 30, 2024 | $14.05M | -15.9% | -12.8% |
| March 31, 2024 | $16.12M | -12.6% | +32.5% |
| December 31, 2023 | $12.17M | -15.8% | -19.2% |
- Quoin Pharmaceuticals, Ltd. showed an increase of +29.8% in Total Assets compared to the prior fiscal year.
- Over the 2016–2025 period, Quoin Pharmaceuticals, Ltd.’s total assets has declined by 39.9% (from $33.91 million to $20.39 million).
- The most recent figure is from Quoin Pharmaceuticals, Ltd.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: